Literature DB >> 16264961

Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.

Edith D Canby-Hagino1, Ian M Thompson.   

Abstract

Prostate cancer is a significant cause of cancer death, making it an attractive target for chemoprevention. Epidemiologic studies and the Prostate Cancer Prevention Trial indicate that chemoprevention is possible. Strategies for prevention include hormonal manipulation and limiting accumulation of genetic damage with anti-inflammatory agents and/or dietary antioxidants. Development of an effective chemoprevention strategy for prostate cancer is evolving and will likely serve as a model for chemoprevention of other adult malignancies.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16264961     DOI： 10.1038/ncponc0172

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


  8 in total

Review 1.  Dietary interventions in prostate cancer.

Authors:  Wendy Demark-Wahnefried
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

2.  Significant cancer prevention factor extraction: an association rule discovery approach.

Authors:  Jesmin Nahar; Kevin S Tickle; A B M Shawkat Ali; Yi-Ping Phoebe Chen
Journal:  J Med Syst       Date:  2009-10-03       Impact factor: 4.460

3.  Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.

Authors:  Wendy Demark-Wahnefried; Thomas J Polascik; Stephen L George; Boyd R Switzer; John F Madden; Mack T Ruffin; Denise C Snyder; Kouros Owzar; Vera Hars; David M Albala; Philip J Walther; Cary N Robertson; Judd W Moul; Barbara K Dunn; Dean Brenner; Lori Minasian; Philip Stella; Robin T Vollmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

Review 4.  Lycopene for the prevention of prostate cancer.

Authors:  Dragan Ilic; Kristian M Forbes; Craig Hassed
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

5.  In silico modelling of hormone response elements.

Authors:  Maria Stepanova; Feng Lin; Valerie C-L Lin
Journal:  BMC Bioinformatics       Date:  2006-12-12       Impact factor: 3.169

Review 6.  Green tea and the risk of prostate cancer: A systematic review and meta-analysis.

Authors:  Yuming Guo; Fan Zhi; Ping Chen; Keke Zhao; Han Xiang; Qi Mao; Xinghuan Wang; Xinhua Zhang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model.

Authors:  Imtiaz A Siddiqui; Yogeshwer Shukla; Vaqar M Adhami; Sami Sarfaraz; Mohammad Asim; Bilal Bin Hafeez; Hasan Mukhtar
Journal:  Pharm Res       Date:  2008-03-04       Impact factor: 4.200

8.  Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.

Authors:  Vasiliki Michopoulou; Stavros P Derdas; Emmanouil Symvoulakis; Nikolaos Mourmouras; Alexandros Nomikos; Dimitris Delakas; George Sourvinos; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2014-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.